William Hait - Apr 21, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Officer
Signature
Raavi Deol, as attorney-in-fact for William Hait
Stock symbol
JNJ
Transactions as of
Apr 21, 2022
Transactions value $
-$2,766,076
Form type
4
Date filed
4/25/2022, 04:33 PM
Previous filing
Feb 18, 2022
Next filing
Oct 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $2.69M +29.7K +37.01% $90.44 110K Apr 21, 2022 Direct
transaction JNJ Common Stock Sale -$18.4K -100 -0.09% $183.58 110K Apr 21, 2022 Direct F1
transaction JNJ Common Stock Sale -$18.4K -100 -0.09% $183.58 110K Apr 21, 2022 Direct F1
transaction JNJ Common Stock Sale -$41.3K -225 -0.21% $183.58 110K Apr 21, 2022 Direct F1
transaction JNJ Common Stock Sale -$129K -700 -0.64% $183.58 109K Apr 21, 2022 Direct F1
transaction JNJ Common Stock Sale -$258K -1.4K -1.29% $183.58 107K Apr 21, 2022 Direct F1
transaction JNJ Common Stock Sale -$311K -1.7K -1.58% $183.58 106K Apr 21, 2022 Direct F1
transaction JNJ Common Stock Sale -$529K -2.88K -2.73% $183.58 103K Apr 21, 2022 Direct F1
transaction JNJ Common Stock Sale -$4.15M -22.6K -21.97% $183.58 80.2K Apr 21, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -29.7K -50% $0.00 29.7K Apr 21, 2022 Common Stock 29.7K $90.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from 183.57 to 183.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer